<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00328900</url>
  </required_header>
  <id_info>
    <org_study_id>S-03113</org_study_id>
    <nct_id>NCT00328900</nct_id>
  </id_info>
  <brief_title>Measurement of Stress During Anesthesia With &quot;Pain Detector&quot; on Patients Receiving Atropine</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rikshospitalet University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rikshospitalet University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      24 patients randomly divided into two groups, one of the groups receiving atropine in
      addition to the planned anaesthesia. Skin conductance parameters to be compared between the
      two groups.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Skin conductance (SC), in terms of numbers of skin conduction fluctuations (NSCF), amplitude
      and mean skin conductance level, reflect the activity in the sympathetic postganglionic
      cholinergic fibers which innervate the palmar and plantar sweat glands. Skin conductance,
      especially numbers of skin conductance fluctuations, may be a promising tool to monitor
      anesthesia. Atropine, an anticholinergic agent, acts as an antagonist on the muscarinic
      receptors of the sweat glands and inhibits their secretion in a dose-dependent way. The aim
      of this study was to find out to what degree SC is influenced by i.v. administration of
      atropine.

      Study hypothesis: SC is not influenced by i.v. administration of atropine.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2006</start_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of skin conductance fluctuations</measure>
  </primary_outcome>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Hemorrhoids</condition>
  <condition>Fissure in Ano</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Administration of 0,7 mg of atropine</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Measurement of skin conductance with Pain detector</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients in ASA-group 1-2

          -  Operations (anal fissures, anal fistulas and haemorrhoids) lasting for less than one
             hour

          -  informed consent

          -  BMI &lt;30

        Exclusion Criteria:

          -  Patients using any medication known to influence the autonomous nervous system

          -  Patients with contraindications to atropine (e.i. fibrillation, glaucoma ect)

          -  BMI &gt;30

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hanne Storm, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Rikshospitalet University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hanne Storm, PhD</last_name>
    <phone>+47 23074398</phone>
    <email>hanne.storm@medisin.uio.no</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ulleval University Hospital</name>
      <address>
        <city>Oslo</city>
        <zip>0407</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hanne Storm, PhD</last_name>
      <phone>+47 23074398</phone>
      <email>hanne.storm@medisin.uio.no</email>
    </contact>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>April 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 22, 2006</study_first_submitted>
  <study_first_submitted_qc>May 22, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 24, 2006</study_first_posted>
  <last_update_submitted>May 31, 2012</last_update_submitted>
  <last_update_submitted_qc>May 31, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 1, 2012</last_update_posted>
  <responsible_party>
    <name_title>Hanne Storm MD.PhD</name_title>
    <organization>Rikshospitalet, UIO</organization>
  </responsible_party>
  <keyword>Galvanic skin response</keyword>
  <keyword>Anesthesia</keyword>
  <keyword>Atropine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhoids</mesh_term>
    <mesh_term>Fissure in Ano</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atropine</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>May 5, 2015</submitted>
    <returned>May 21, 2015</returned>
    <submitted>April 24, 2017</submitted>
    <returned>August 2, 2017</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

